Natural killer cells: role in local tumor growth and metastasis

References

• KiesslingRKleinEWigzellH“Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotypeEur J Immunol1975521121171234049
   PubMed Web of Science ®Google Scholar
• BironCAvan den ElsenPTuttMMMedveczkyPKumarVTerhorstCMurine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genesJ Immunol19871395170417103497976
   PubMed Web of Science ®Google Scholar
• Di SantoJPNatural killer cell developmental pathways: a question of balanceAnnu Rev Immunol20062425728616551250
   PubMed Web of Science ®Google Scholar
• KärreKLjunggrenHGPiontekGKiesslingRSelective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategyNature198631960556756783951539
   PubMed Web of Science ®Google Scholar
• LanierLLNatural killer cells: from no receptors to too manyImmunity1997643713789133416
   PubMed Web of Science ®Google Scholar
• RauletDHVanceREMcMahonCWRegulation of the natural killer cell receptor repertoireAnnu Rev Immunol20011929133011244039
   PubMed Web of Science ®Google Scholar
• LanierLLMissing self, NK cells, and the white albumJ Immunol200517411656515905491
   PubMed Web of Science ®Google Scholar
• CaligiuriMAHuman natural killer cellsBlood2008112346146918650461
   PubMed Web of Science ®Google Scholar
• VivierETomaselloEBaratinMWalzerTUgoliniSFunctions of natural killer cellsNat Immunol20089550351018425107
   PubMed Web of Science ®Google Scholar
• WuJLanierLLNatural killer cells and cancerAdv Cancer Res20039012715614710949
   PubMed Web of Science ®Google Scholar
• KingABurrowsTLokeYWHuman uterine natural killer cellsNat Immun199615141529032767
   PubMedGoogle Scholar
• LuoDVermijlenDVanderkerkenKInvolvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cellsJ Hepatol199931111011610424290
   PubMed Web of Science ®Google Scholar
• RobertsonMJRitzJBiology and clinical relevance of human natural killer cellsBlood19907612242124382265240
   PubMed Web of Science ®Google Scholar
• TrinchieriGBiology of natural killer cellsAdv Immunol1989471873762683611
   PubMed Web of Science ®Google Scholar
• NaglerALanierLLCwirlaSPhillipsJHComparative studies of human FcRIII-positive and negative natural killer cellsJ Immunol198914310318331912530273
   PubMed Web of Science ®Google Scholar
• CooperMAFehnigerTATurnerSCHuman natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subsetBlood200197103146315111342442
   PubMed Web of Science ®Google Scholar
• HayakawaYSmythMJCD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacityJ Immunol200617631517152416424180
   PubMed Web of Science ®Google Scholar
• WalzerTBleryMChaixJIdentification, activation, and selective in vivo ablation of mouse NK cells via NKp46Proc Natl Acad Sci U S A200710493384338917360655
   PubMed Web of Science ®Google Scholar
• GongJHMakiGKlingemannHGCharacterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cellsLeukemia1994846526588152260
   PubMed Web of Science ®Google Scholar
• ChengMMaJChenYEstablishment, characterization and successful adaptive therapy against human tumors of NKG Cell, a new human NK cell lineCell TransplantJune 72011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• OrtaldoJROldhamRKCannonGCHerbermanRBSpecificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell lineJ Natl Cancer Inst1977591778269036
   PubMedGoogle Scholar
• RiccardiCSantoniABarlozzariTPuccettiPHerbermanRBIn vivo natural reactivity of mice against tumor cellsInt J Cancer19802544754866154658
   PubMed Web of Science ®Google Scholar
• KimSIizukaKAguilaHLWeissmanILYokoyamaWMIn vivo natural killer cell activities revealed by natural killer cell-deficient miceProc Natl Acad Sci U S A20009762731273610694580
   PubMed Web of Science ®Google Scholar
• SmythMJCretneyETakedaKTumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasisJ Exp Med2001193666167011257133
   PubMed Web of Science ®Google Scholar
• SmythMJCroweNYGodfreyDINK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcomaInt Immunol200113445946311282985
   PubMed Web of Science ®Google Scholar
• HalfteckGGElboimMGurCAchdoutHGhadiallyHMandelboimOEnhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1J Immunol200918242221223019201876
   PubMed Web of Science ®Google Scholar
• LodoenMBLanierLLViral modulation of NK cell immunityNat Rev Microbiol200531596915608700
   PubMed Web of Science ®Google Scholar
• GarridoFAlgarraIMHC antigens and tumor escape from immune surveillanceAdv Cancer Res20018311715811665717
   PubMed Web of Science ®Google Scholar
• HewittEWThe MHC class I antigen presentation pathway: strategies for viral immune evasionImmunology2003110216316914511229
   PubMed Web of Science ®Google Scholar
• ClementMVHaddadPSoulieAInvolvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cellsRes Immunol199014164774892284495
   PubMedGoogle Scholar
• BrycesonYTMarchMELjunggrenHGLongEOActivation, coactivation, and costimulation of resting human natural killer cellsImmunol Rev2006214739117100877
   PubMed Web of Science ®Google Scholar
• KagiDLedermannBBurkiKCytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature1994369647531378164737
   PubMed Web of Science ®Google Scholar
• SmythMJThiaKYStreetSEMacGregorDGodfreyDITrapaniJAPerforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphomaJ Exp Med2000192575576010974040
   PubMed Web of Science ®Google Scholar
• CaoXCaiSFFehnigerTAGranzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearanceImmunity200727463564617919943
   PubMed Web of Science ®Google Scholar
• ZamaiLAhmadMBennettIMAzzoniLAlnemriESPerussiaBNatural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cellsJ Exp Med199818812237523809858524
   PubMed Web of Science ®Google Scholar
• TakedaKHayakawaYSmythMJInvolvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cellsNat Med2001719410011135622
   PubMed Web of Science ®Google Scholar
• TrinchieriGNatural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesisSemin Immunol19957283887579198
   PubMedGoogle Scholar
• StreetSECretneyESmythMJPerforin and interferon-gamma activities independently control tumor initiation, growth, and metastasisBlood200197119219711133760
   PubMed Web of Science ®Google Scholar
• AngiolilloALSgadariCTaubDDHuman interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivoJ Exp Med199518211551627540647
   PubMed Web of Science ®Google Scholar
• BironCANguyenKBPienGCCousensLPSalazar-MatherTPNatural killer cells in antiviral defense: function and regulation by innate cytokinesAnnu Rev Immunol19991718922010358757
   PubMed Web of Science ®Google Scholar
• SnijdersAKalinskiPHilkensCMKapsenbergMLHigh-level IL-12 production by human dendritic cells requires two signalsInt Immunol19981011159315989846688
   PubMed Web of Science ®Google Scholar
• AdamCKingSAllgeierTDC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL inductionBlood2005106133834415769894
   PubMed Web of Science ®Google Scholar
• JacobsNBoniverJHubertPDelvennePDendritic cells: more than just adaptive immunity inducers?Curr Immunol Rev200731722
   Google Scholar
• LjunggrenHGKärreKHost resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanismJ Exp Med19851626174517593877776
   PubMed Web of Science ®Google Scholar
• FrankssonLGeorgeEPowisSButcherGHowardJKärreKTumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter geneJ Exp Med199317712012058418201
   PubMed Web of Science ®Google Scholar
• LjunggrenHGSturmhofelKWolpertEHammerlingGJKärreKTransfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variantsJ Immunol199014513803862113557
   PubMed Web of Science ®Google Scholar
• WagtmannNRajagopalanSWinterCCPeruzziMLongEOKiller cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transferImmunity1995368018098777725
   PubMed Web of Science ®Google Scholar
• JamilKMKhakooSIKIR/HLA interactions and pathogen immunityJ Biomed Biotechnol2011201129834821629750
   PubMedGoogle Scholar
• YokoyamaWMJacobsLBKanagawaOShevachEMCohenDIA murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteinsJ Immunol19891434137913862787364
   PubMed Web of Science ®Google Scholar
• OrrMTLanierLLInhibitory Ly49 receptors on mouse natural killer cellsCurr Top Microbiol Immunol2011350678720680808
   PubMed Web of Science ®Google Scholar
• CarreteroMCantoniCBellonTThe CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I moleculesEur J Immunol19972725635679045931
   PubMed Web of Science ®Google Scholar
• HouchinsJPYabeTMcSherryCBachFHDNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cellsJ Exp Med19911734101710202007850
   PubMed Web of Science ®Google Scholar
• PetrieEJClementsCSLinJCD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequenceJ Exp Med2008205372573518332182
   PubMed Web of Science ®Google Scholar
• Le DreanEVelyFOlceseLInhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2 A: association of NKG2 A with SHP-1 and SHP-2 protein-tyrosine phosphatasesEur J Immunol19982812642769485206
   PubMed Web of Science ®Google Scholar
• MasilamaniMNguyenCKabatJBorregoFColiganJCD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapseJ Immunol200617763590359616951318
   PubMed Web of Science ®Google Scholar
• CarreteroMPalmieriGLlanoMSpecific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectantsEur J Immunol1998284128012919565368
   PubMed Web of Science ®Google Scholar
• BauerSGrohVWuJActivation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICAScience1999285542872772910426993
   PubMed Web of Science ®Google Scholar
• BiassoniRNatural killer cell receptorsAdv Exp Med Biol2008640355219065782
   PubMed Web of Science ®Google Scholar
• SivoriSVitaleMMorelliLp46, a novel natural killer cell-specific surface molecule that mediates cell activationJ Exp Med19971867112911369314561
   PubMed Web of Science ®Google Scholar
• BrycesonYTMarchMEBarberDFLjunggrenHGLongEOCytolytic granule polarization and degranulation controlled by different receptors in resting NK cellsJ Exp Med200520271001101216203869
   PubMed Web of Science ®Google Scholar
• LanierLLCorlissBCWuJLeongCPhillipsJHImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cellsNature199839166687037079490415
   PubMed Web of Science ®Google Scholar
• OlceseLCambiaggiASemenzatoGBottinoCMorettaAVivierEHuman killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cellsJ Immunol199715811508350869164921
   PubMed Web of Science ®Google Scholar
• MoldovanIGalonJMaridonneau-PariniIRegulation of production of soluble Fc gamma receptors type III in normal and pathological conditionsImmunol Lett199968112513410397167
   PubMed Web of Science ®Google Scholar
• NimmerjahnFRavetchJVAntibodies, Fc receptors and cancerCurr Opin Immunol200719223924517291742
   PubMed Web of Science ®Google Scholar
• RenouxVBisigBLangersIHuman papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretionEur J Immunol201144113240325221830210
   PubMed Web of Science ®Google Scholar
• HoELHeuselJWBrownMGMatsumotoKScalzoAAYokoyamaWMMurine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cellsProc Natl Acad Sci U S A19989511632063259600963
   PubMed Web of Science ®Google Scholar
• ChampsaurMLanierLLEffect of NKG2D ligand expression on host immune responsesImmunol Rev2010235126728520536569
   PubMed Web of Science ®Google Scholar
• RosenDBArakiMHamermanJAChenTYamamuraTLanierLLA Structural basis for the association of DAP12 with mouse, but not human, NKG2DJ Immunol200417342470247815294961
   PubMed Web of Science ®Google Scholar
• SutherlandCLChalupnyNJSchooleyKVandenBosTKubinMCosmanDUL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cellsJ Immunol2002168267167911777960
   PubMed Web of Science ®Google Scholar
• GrohVBahramSBauerSHermanABeauchampMSpiesTCell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epitheliumProc Natl Acad Sci U S A1996932212445124508901601
   PubMed Web of Science ®Google Scholar
• CerwenkaANew twist on the regulation of NKG2D ligand expressionJ Exp Med2009206226526819204110
   PubMed Web of Science ®Google Scholar
• CantoniCBottinoCVitaleMNKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamilyJ Exp Med1999189578779610049942
   PubMed Web of Science ®Google Scholar
• PendeDParoliniSPessinoAIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsJ Exp Med1999190101505151610562324
   PubMed Web of Science ®Google Scholar
• BottinoCBiassoniRMilloRMorettaLMorettaAThe human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggeringHum Immunol20006111610658972
   PubMed Web of Science ®Google Scholar
• CostelloRTSivoriSMarcenaroEDefective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemiaBlood200299103661366711986221
   PubMed Web of Science ®Google Scholar
• PessinoASivoriSBottinoCMolecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityJ Exp Med199818859539609730896
   PubMed Web of Science ®Google Scholar
• SivoriSPendeDBottinoCNKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cellsEur J Immunol19992951656166610359120
   PubMed Web of Science ®Google Scholar
• VitaleMBottinoCSivoriSNKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisJ Exp Med199818712206520729625766
   PubMed Web of Science ®Google Scholar
• BloushtainNQimronUBar-IlanAMembrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46J Immunol200417342392240115294952
   PubMed Web of Science ®Google Scholar
• HechtMLRosentalBHorlacherTNatural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequencesJ Proteome Res20098271272019196184
   PubMed Web of Science ®Google Scholar
• Pogge von StrandmannESimhadriVRvon TresckowBHuman leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cellsImmunity200727696597418055229
   PubMed Web of Science ®Google Scholar
• BrandtCSBaratinMYiECThe B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansJ Exp Med200920671495150319528259
   PubMed Web of Science ®Google Scholar
• StaggJSmythMJNK cell-based cancer immunotherapyDrug News Perspect200720315516317520092
   PubMedGoogle Scholar
• DiefenbachAJensenERJamiesonAMRauletDHRae1 and H60 ligands of the NKG2D receptor stimulate tumour immunityNature2001413685216517111557981
   PubMed Web of Science ®Google Scholar
• PendeDCantoniCRiveraPRole of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial originEur J Immunol20013141076108611298332
   PubMed Web of Science ®Google Scholar
• SobolevOSternPLacy-HulbertAHynesRONatural killer cells require selectins for suppression of subcutaneous tumorsCancer Res20096962531253919258505
   PubMed Web of Science ®Google Scholar
• SmythMJSwannJCretneyEZerafaNYokoyamaWMHayakawaYNKG2D function protects the host from tumor initiationJ Exp Med2005202558358816129707
   PubMed Web of Science ®Google Scholar
• StreetSEHayakawaYZhanYInnate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cellsJ Exp Med2004199687988415007091
   PubMed Web of Science ®Google Scholar
• ZhouSKawakamiSHiguchiYYamashitaFHashidaMThe involvement of NK cell activation following intranasal administration of CpG DNA lipoplex in the prevention of pulmonary metastasis and peritoneal dissemination in miceClin Exp Metastasis2012291637022052391
   PubMed Web of Science ®Google Scholar
• KsienzykANeumannBNandakumarRIRF-1 expression is essential for natural killer cells to suppress metastasisCancer Res201171206410641821900395
   PubMed Web of Science ®Google Scholar
• ImaiKMatsuyamaSMiyakeSSugaKNakachiKNatural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general populationLancet200035692441795179911117911
   PubMed Web of Science ®Google Scholar
• WarrenRPStembridgeAMGardnerEJDeficient immune function of peripheral blood mononuclear cells from patients with Gardner syndromeClin Exp Immunol19856035255313160513
   PubMed Web of Science ®Google Scholar
• MarkowitzJFAigesHWCunningham-RundlesSCancer family syndrome: marker studiesGastroenterology19869135815892942437
   PubMed Web of Science ®Google Scholar
• JovićVKonjevićGRadulovićSJelićSSpuzićIImpaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanomaTumori200187532432911765182
   PubMed Web of Science ®Google Scholar
• RichardsJOChangXBlaserBWCaligiuriMAZhengPLiuYTumor growth impedes natural-killer-cell maturation in the bone marrowBlood2006108124625216556890
   PubMed Web of Science ®Google Scholar
• ReschnerAHubertPDelvennePBoniverJJacobsNInnate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune responseClin Exp Immunol2008152221922618336590
   PubMed Web of Science ®Google Scholar
• KellyJMDarcyPKMarkbyJLInduction of tumor-specific T cell memory by NK cell-mediated tumor rejectionNat Immunol200231839011743585
   PubMed Web of Science ®Google Scholar
• MocikatRBraumullerHGumyANatural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responsesImmunity200319456156914563320
   PubMed Web of Science ®Google Scholar
• GrimmEAMazumderAZhangHZRosenbergSALymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytesJ Exp Med19821556182318416176669
   PubMed Web of Science ®Google Scholar
• AtkinsMBLotzeMTDutcherJPHigh-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993J Clin Oncol19991772105211610561265
   PubMed Web of Science ®Google Scholar
• SosmanJAHankJAMooreKHProlonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinomaCancer Invest19919135482012995
   PubMed Web of Science ®Google Scholar
• BergerCBergerMHackmanRCSafety and immunologic effects of IL-15 administration in nonhuman primatesBlood2009114122417242619605850
   PubMed Web of Science ®Google Scholar
• LauwerysBRGarotNRenauldJCHoussiauFACytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18J Immunol200016541847185310925263
   PubMed Web of Science ®Google Scholar
• GolabJZagozdzonRKozarKPotentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivoOncol Rep20007117718110601614
   PubMed Web of Science ®Google Scholar
• SondelPMHankJAAntibody-directed, effector cell-mediated tumor destructionHematol Oncol Clin North Am200115470372111676280
   PubMed Web of Science ®Google Scholar
• WinterMCHancockBWTen years of rituximab in NHLExpert Opin Drug Saf20098222323519243307
   PubMed Web of Science ®Google Scholar
• Garnock-JonesKPKeatingGMScottLJTrastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancerDrugs201070221523920108993
   PubMed Web of Science ®Google Scholar
• Garcia-FoncillasJDiaz-RubioEProgress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcomeClin Transl Oncol201012853354220709651
   PubMed Web of Science ®Google Scholar
• NavidFSantanaVMBarfieldRCAnti-GD2 antibody therapy for GD2-expressing tumorsCurr Cancer Drug Targets201010220020920201786
   PubMed Web of Science ®Google Scholar
• Bekaii-SaabTSRodaJMGuenterbergKDA phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignanciesMol Cancer Ther20098112983299119887543
   PubMed Web of Science ®Google Scholar
• KohCYBlazarBRGeorgeTAugmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivoBlood200197103132313711342440
   PubMed Web of Science ®Google Scholar
• AliciEIPH-2101, a fully human anti-NK-cell inhibitory receptor mAb for the potential treatment of hematological cancersCurr Opin Mol Ther201012672473321154164
   PubMedGoogle Scholar
• PegramHJRitchieDSSmythMJAlloreactive natural killer cells in hematopoietic stem cell transplantationLeuk Res2011351142120719383
   PubMed Web of Science ®Google Scholar
• Van TendelooVFVan de VeldeAVan DriesscheAInduction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationProc Natl Acad Sci U S A201010731138241382920631300
   PubMed Web of Science ®Google Scholar
• ViaudSTheryCPloixSDendritic cell-derived exosomes for cancer immunotherapy: what’s next?Cancer Res20107041281128520145139
   PubMed Web of Science ®Google Scholar
• HallezSSimonPMaudouxFPhase I/II immunogenicity of a Human Papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasiaCancer Immunol Immunother200453764265014985860
   PubMed Web of Science ®Google Scholar
• HubertPDoyenJCapelleXLocal applications of GM-CSF induce the recruitment of immune cells in cervical low-grade squamous intraepithelial lesionsAm J Reprod Immunol20106412613620367631
   PubMed Web of Science ®Google Scholar
• AndresenLSkovbakkeSPerssonG2-Deoxy d-glucose prevents cell surface expression of nkg2d ligands through inhibition of n-linked glycosylationJ Immunol201218841847185522227571
   PubMed Web of Science ®Google Scholar
• GasserSOrsulicSBrownEJRauletDHThe DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature200543670541186119015995699
   PubMed Web of Science ®Google Scholar
• LunemannALunemannJDMunzCRegulatory NK-cell functions in inflammation and autoimmunityMol Med2009159–1035235819603102
   PubMed Web of Science ®Google Scholar
• ShiFDLjunggrenHGSarvetnickNInnate immunity and autoimmunity: from self-protection to self-destructionTrends Immunol20012229710111286711
   PubMed Web of Science ®Google Scholar
• ShahAARosenACancer and systemic sclerosis: novel insights into pathogenesis and clinical implicationsCurr Opin Rheumatol201123653053521825998
   PubMed Web of Science ®Google Scholar
• AmosSMDuongCPWestwoodJAAutoimmunity associated with immunotherapy of cancerBlood2011118349950921531979
   PubMed Web of Science ®Google Scholar
• ShiFDZhouQNatural killer cells as indispensable players and therapeutic targets in autoimmunityAutoimmunity201144131020701455
   PubMed Web of Science ®Google Scholar
• ShiFDWangHBLiHNatural killer cells determine the outcome of B cell-mediated autoimmunityNat Immunol20001324525110973283
   PubMed Web of Science ®Google Scholar
• KitaichiNKotakeSMorohashiTOnoeKOhnoSTaylorAWDiminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cellsJ Leukoc Biol20027261117112112488492
   PubMed Web of Science ®Google Scholar
• Erkeller-YuselFHulstaartFHannetIIsenbergDLydyardPLymphocyte subsets in a large cohort of patients with systemic lupus erythematosusLupus1993242272318268970
   PubMed Web of Science ®Google Scholar
• AramakiTIdaHIzumiYA significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritisMod Rheumatol200919324525219283441
   PubMed Web of Science ®Google Scholar
• BielekovaBCatalfamoMReichert-ScrivnerSRegulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosisProc Natl Acad Sci U S A2006103155941594616585503
   PubMed Web of Science ®Google Scholar
• LiZLimWKMaheshSPLiuBNussenblattRBCutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitisJ Immunol200517495187519115843513
   PubMed Web of Science ®Google Scholar
• OgasawaraKHamermanJAHsinHImpairment of NK cell function by NKG2D modulation in NOD miceImmunity2003181415112530974
   PubMed Web of Science ®Google Scholar
• NamekawaTSnyderMRYenJHKiller cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritisJ Immunol200016521138114510878393
   PubMed Web of Science ®Google Scholar
• MartinMPNelsonGLeeJHCutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C allelesJ Immunol200216962818282212218090
   PubMed Web of Science ®Google Scholar
• MomotTKochSHunzelmannNAssociation of killer cell immunoglobulin-like receptors with sclerodermaArthritis Rheum20045051561156515146426
   PubMed Web of Science ®Google Scholar
• SuzukiYHamamotoYOgasawaraYGenetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgarisJ Invest Dermatol200412251133113615140215
   PubMed Web of Science ®Google Scholar